Vstm Stock Quote: Verastem's Journey to Cancer-Focused Trading Success

Verastem's journey to cancer-focused trading success began with the company's inception in 2010. Verastem was founded by Robert Forrester, a seasoned biotech executive.

The company's initial focus was on developing cancer therapies, and its first product candidate was VS-6063, a small molecule inhibitor of the PI3K/AKT pathway. This pathway is a key regulator of cell growth and survival, making it an attractive target for cancer treatment.

In 2013, Verastem went public with an initial public offering (IPO) that raised $75 million in funding. This influx of capital enabled the company to advance its pipeline and expand its research and development efforts.

VSTM stock quote investors should note that the company's revenue has been steadily increasing over the past few years.

As of the latest financial reports, VSTM's revenue has grown by 25% from 2020 to 2022.

The company's net income has also shown a significant improvement, with a 30% increase in 2022 compared to the previous year.

This growth can be attributed to VSTM's successful product launches and strategic partnerships, which have helped expand its customer base and increase sales.

When it comes to analyst forecasts, one thing is clear: they can be a powerful tool for investors. The average rating for VSTM stock is "Strong Buy" according to 8 analysts.

This is a significant endorsement, and it's no wonder that investors are taking notice. The 12-month stock price forecast is $12.33.

This represents a substantial increase of 111.86% from the latest price.

Delayed NSDQ Data can be a bit unsettling, especially if you're used to seeing up-to-the-minute numbers. The latest update on NSDQ is $5.81, with a slight drop of $0.01 (-0.17%) at 7:58 PM ET.

You can use the Zacks Rank system to gauge the potential of stocks over the next 1 to 3 months. The system assigns a score from 1 to 5, with 1 being a Strong Buy and 5 being a Strong Sell. According to the article, a Strong Buy has an annualized return of 24.30%.

Here's a breakdown of the Zacks Rank scores:

The scores are based on trading styles like Value, Growth, and Momentum, which are combined into a VGM Score. This score is a weighted average of the individual style scores.